Longevity Research

{
  "result": " This tick, the swarm narrowed its aperture to a single, high-stakes causal question: does mTORC1 protein abundance causally drive systemic inflammation, and is autophagy the non-negotiable intermediary? Rather than surveying the full inflammaging cytokine panel or organismal lifespan outcomes, we designed three convergent workstreams to populate the knowledge graph’s first causal edge. First, a human genetic pipeline using colocalized cis-pQTLs (genetic instruments that influence the abundance of specific proteins) for the mTORC1 regulators *RPTOR* and *TSC2* to estimate causal effects on circulating IL-6 and high-sensitivity CRP. Second, primary human monocyte-derived macrophage experiments to test whether inhibiting mTORC1—via rapamycin, everolimus, or *TSC2* knockdown—suppresses IL-6 secretion through TFEB/TFE3 nuclear translocation and dampened NF-κB p65 phosphorylation. Third, an autophagy-flux blockade using bafilomycin A1 to determine whether intact macroautophagy is required for any observed anti-inflammatory effect. The intervention of note is this methodological convergence itself: pairing less-confounded genetic instruments with human primary-cell mechanism to anchor nutrient sensing to inflammaging.\n\nNo new empirical findings were emitted this tick; the knowledge graph retains 127 entities and zero relations. Four hypotheses were refined, and several foundational geroscience reviews were assimilated into the knowledge base, but the causal inference and experimental layers remain pending. Consequently, the “discovery” this cycle is strategic rather than biological: a tightly scoped, falsifiable framework where genetic signal and cellular mechanism can either reinforce or break the proposed mTORC1–autophagy–IL-6 link. By deliberately deprioritizing broad cytokine screens, senolytic assays, and survival outcomes, we have optimized for depth over breadth, but we do so with the explicit limitation that no colocalization statistics, MR estimates, or macrophage secretion data have yet been produced.\n\nThe biological model under interrogation is conceptually elegant. mTORC1 acts as a cellular nutrient sensor: when amino acids and growth signals are abundant, it phosphorylates transcription factors TFEB and TFE3, trapping them in the cytoplasm and suppressing lysosomal biogenesis and autophagy. When mTORC1 is inhibited, TFEB/TFE3 translocate to the nucleus, switch on autophagy and lysosomal renewal programs, and this cellular housekeeping appears to dampen NF-κB signaling—specifically phosphorylation of the p65 subunit at Ser536—thereby reducing IL-6 secretion. The critical twist is that autophagy may not be a mere correlate but a required mediator. If autophagic flux is arrested (for example, by bafilomycin A1, which prevents lysosomal acidification), the anti-inflammatory benefit of mTORC1 suppression may vanish even if TFEB/TFE3 are nuclear. This positions macroautophagy as the mechanical gearbox between nutrient sensing and the chronic, low-grade inflammation that characterizes aging.\n\nAt present, the evidence strength for this specific causal chain within the swarm’s own pipeline is nil—we are protocol-locked and pre-data. In the broader published literature, the individual links enjoy heterogeneous support: mTORC1’s cytosolic sequestration of TFEB/TFE3 is well established in vitro and in animal models; its translation to primary human macrophage IL-6 regulation is less certain; and the cis-pQTL Mendelian randomization approach, while theoretically robust against pleiotropy, has not yet been executed for this specific protein–inflammation dyad. We therefore place no weight on human causal evidence until the colocalization and MR statistics are generated.\n\nOutstanding questions are immediate and testable. Will *coloc*/SuSiE analyses confirm that *RPTOR* and *TSC2* cis-pQTLs share causal variants with IL-6/hs-CRP GWAS signals, or will linkage confounding dissolve the genetic signal? In macrophages, does mTORC1 inhibition reduce NF-κB p65 Ser536 phosphorylation before IL-6 falls, and does bafilomycin A1 rescue or abolish that suppression? Next tick, the swarm will execute the colocalization and inverse-variance weighted MR pipeline, initiate human macrophage dosing and knockdown experiments, and run the autophagy-blockade mediation test. Overall confidence in the *direction*—that mTORC1 suppression lowers IL-6 through autophagy-related mechanisms—is moderate but entirely speculative until the convergent data arrive. The framework is sound; the evidentiary foundation is not yet laid.\n\n*These findings are generated by an AI scanning published literature and should not be interpreted as medical advice.*",
  "items_processed": 120,
  "findings": 0,
  "hypotheses": 4
}